CLINICAL_TRIALS
trial_result
· 2016-09-29
Clinical Trial Update: A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma [Phase 2]
Summary
Phase 2 results from a safety and efficacy study of inhaled R940343 in patients with mild to moderate asthma have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rigel Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2016-09-29